| 000 | 01837 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250517132736.0 | ||
| 264 | 0 | _c20171128 | |
| 008 | 201711s 0 0 eng d | ||
| 022 | _a1756-8722 | ||
| 024 | 7 |
_a10.1186/s13045-016-0369-8 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDaud, Adil | |
| 245 | 0 | 0 |
_aIndirect treatment comparison of dabrafenib plus trametinib versus vemurafenib plus cobimetinib in previously untreated metastatic melanoma patients. _h[electronic resource] |
| 260 |
_bJournal of hematology & oncology _c01 2017 |
||
| 300 |
_a3 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
| 650 | 0 | 4 |
_aAzetidines _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImidazoles _xadministration & dosage |
| 650 | 0 | 4 |
_aIndoles _xadministration & dosage |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMelanoma _xcomplications |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeoplasm Metastasis |
| 650 | 0 | 4 |
_aOximes _xadministration & dosage |
| 650 | 0 | 4 |
_aPiperidines _xadministration & dosage |
| 650 | 0 | 4 |
_aPyridones _xadministration & dosage |
| 650 | 0 | 4 |
_aPyrimidinones _xadministration & dosage |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 650 | 0 | 4 |
_aSulfonamides _xadministration & dosage |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aVemurafenib |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aGill, Japinder | |
| 700 | 1 | _aKamra, Sheily | |
| 700 | 1 | _aChen, Lei | |
| 700 | 1 | _aAhuja, Amit | |
| 773 | 0 |
_tJournal of hematology & oncology _gvol. 10 _gno. 1 _gp. 3 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1186/s13045-016-0369-8 _zAvailable from publisher's website |
| 999 |
_c26752809 _d26752809 |
||